Paraffin Bath Therapy for Chronic Hand Eczema
- Conditions
- Eczema
- Interventions
- Other: Paraffin baths therapy
- Registration Number
- NCT04510961
- Lead Sponsor
- Cairo University
- Brief Summary
Objective: Chronic Hand eczema (CHE) is a common inflammatory skin disease has a major medical psychological and socio-economic implications that affect quality of life (QoL)and work ability. This study, the first randomized controlled trial that will be conducted to evaluate the effect of paraffin bath therapy (PBT) in the treatment of CHE.
- Detailed Description
Design: The study design is a randomized controlled trial with measures at pre-and post-intervention.
Subjects: Sixty patients with moderate to severe Chronic Hand eczema (CHE) will participate in the study. They will be classified randomly into two groups of equal number; paraffin group and the control group.
Interventions: Paraffin group will receive Paraffin bath therapy for 5 days per week for 12 weeks in addition to routine skin care program while the control group will receive routine skin care program.
Outcome Measures:
Objective SCORing Atopic Dermatitis, subjective item score and dermatology life quality index (DLQI) will be assessed before, at 6th week and at 12th week of treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Age from 20-40 years
- Time elapsed from the beginning of the disease ; more than three months according to the Guideline of the German Dermatological Society
- active eczematous lesions on other parts of the body;
- malignant or premalignant skin tumors
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Paraffin baths therapy (PBT) :group A Paraffin baths therapy Patients in treatment group will receive paraffin wax baths for five days per week for 12 weeks.
- Primary Outcome Measures
Name Time Method SCORAD ("SCORing Atopic Dermatitis Change from Baseline at SCORAD score at 6th week and at 12th weeks of treatment is the most widely clinical tool for assessing the severity (i.e. extent, intensity) of atopic dermatitis as objectively as possible.20 It consists of six objective items (erythema, oedema/papules, effect of scratching, oozing/crust formation, lichenification, and dryness), and two subjective symptoms (itch and sleeplessness), the maximum score is 103 points
- Secondary Outcome Measures
Name Time Method Dermatology life quality index (DLQI) Change from Baseline at 6th week and at 12th weeks of treatment DLQI consists of ten questions describe symptoms, feelings, leisure activities, work or school activities, personal relationships and treatment
Trial Locations
- Locations (1)
Zizi Mohammed Ibrahim Ali
🇸🇦Riyadh, Saudi Arabia